Forbes J M & CO LLP Merck & Co., Inc. Transaction History

Forbes J M & CO LLP

$1 Billion
Q3 2024

A detailed history of Forbes J M & CO LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 162,736 shares of MRK stock, worth $16.2 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

162,736

Previous 165,006 1.38%

Holding current value

$16.2 Million

Previous $20.4 Million 9.53%

% of portfolio

1.84%

Previous 2.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$111.15 - $128.97 $252,310 - $292,761	-2,270 Reduced 1.38%	162,736 $18.5 Million
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $385,265 - $413,771	3,112 Added 1.92%	165,006 $20.4 Million
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $210,060 - $244,767	-1,855 Reduced 1.13%	161,894 $21.4 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $329,692 - $358,784	3,291 Added 2.05%	163,749 $17.9 Million
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $3.34 Million - $3.71 Million	-32,409 Reduced 16.8%	160,458 $16.5 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $2.1 Million - $2.29 Million	-19,304 Reduced 9.1%	192,867 $22.3 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $276,599 - $308,628	2,687 Added 1.28%	212,171 $22.6 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $55,961 - $71,750	640 Added 0.31%	209,484 $23.2 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $335,668 - $377,086	3,971 Added 1.94%	208,844 $18 Million
Q2 2022 Jul 22, 2022	SELL	$83.49 - $94.64 $34,898 - $39,559	-418 Reduced 0.2%	204,873 $18.7 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $38,078 - $42,683	518 Added 0.25%	205,291 $16.8 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $75,388 - $94,433	1,043 Added 0.51%	204,773 $15.7 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $167,014 - $183,673	2,330 Added 1.16%	203,730 $15.3 Million
Q2 2021 Aug 03, 2021	BUY	$70.31 - $77.77 $73,614 - $81,425	1,047 Added 0.52%	201,400 $15.7 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $189,847 - $223,620	2,757 Added 1.4%	200,353 $15.4 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $171,673 - $190,522	2,392 Added 1.23%	197,596 $16.2 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $347,165 - $393,514	4,744 Added 2.49%	195,204 $16.2 Million
Q2 2020 Aug 07, 2020	BUY	$70.42 - $80.13 $6,337 - $7,211	90 Added 0.05%	190,460 $14.7 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $248,751 - $344,781	3,926 Added 2.11%	190,370 $14.6 Million
Q4 2019 Feb 07, 2020	BUY	$77.58 - $87.54 $1.01 Million - $1.14 Million	13,036 Added 7.52%	186,444 $17 Million
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $74,634 - $81,354	981 Added 0.57%	173,408 $14.6 Million
Q2 2019 Aug 02, 2019	BUY	$69.84 - $81.59 $1.12 Million - $1.31 Million	16,060 Added 10.27%	172,427 $14.5 Million
Q1 2019 May 07, 2019	BUY	$69.58 - $79.36 $116,894 - $133,324	1,680 Added 1.09%	156,367 $13 Million
Q4 2018 Jan 25, 2019	SELL	$65.24 - $75.71 $113,321 - $131,508	-1,737 Reduced 1.11%	154,687 $11.8 Million
Q3 2018 Nov 02, 2018	SELL	$57.69 - $67.84 $25,498 - $29,985	-442 Reduced 0.28%	156,424 $11.1 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $23,483 - $27,590	462 Added 0.3%	156,866 $9.52 Million
Q1 2018 Apr 18, 2018	BUY	$50.96 - $59.23 $86,377 - $100,394	1,695 Added 1.1%	156,404 $8.52 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $138,031 - $164,825	2,674 Added 1.76%	154,709 $8.71 Million
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $105,664 - $113,697	-1,801 Reduced 1.17%	152,035 $9.73 Million
Q2 2017 Aug 10, 2017	BUY	N/A	153,836	153,836 $9.86 Million

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.

Account